Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease
Clinical trial NCT06572267 · RECRUITING
Trial details
- NCT number
- NCT06572267
- Sponsor
- Xijing Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-16
- Primary completion
- 2026-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.